Pandemic impact on aneurysmal subarachnoid hemorrhage in Peru’s high COVID-19 lethality setting: A public institutional experience
Authors:
- Jose Daniel Flores-SanchezJFJose Daniel Flores-Sanchez
- Daniela Alejandra Perez-ChadidDPDaniela Alejandra Perez-Chadid
- John Vargas-UrbinaJVJohn Vargas-Urbina
- Jorge ZumaetaJZJorge Zumaeta
- Rommel Roger RodriguezRRRommel Roger Rodriguez
- Fernando PalaciosFPFernando Palacios
- Jerson Flores-CastilloJFJerson Flores-Castillo
Open Access
- 22 December 2023
- journal article
- research article
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 440
Abstract
The COVID-19 pandemic in 2020 profoundly impacted healthcare worldwide, and Peru was particularly affected, experiencing the highest COVID-19 case fatality rate globally. We conducted a retrospective comparative study of patients presenting with aneurysmal subarachnoid hemorrhage (SAH) at a public Peruvian national referral center specializing in cerebrovascular diseases. Two study periods were considered, one during the first wave of the COVID-19 pandemic and a second identical period in 2019. Variables included patient demographics, comorbidities, COVID-19 infection status, clinical presentation, treatment approaches, and hospital outcomes. We analyzed 114 patients with aneurysmal SAH, 65 (57.0%) treated in 2019 and 49 (43.0%) in 2020. The mean time from emergency admission to the day of definitive treatment during 2019 and 2020 was 2.72 and 1.93 days, respectively. Likewise, the mean time from symptom onset to the date of definitive treatment was 6.71 and 7.70 days, respectively. We identified significant associations between complications such as sepsis, respiratory failure, acute kidney failure, and hospital mortality. The proportion of fatalities was significantly higher in 2020 compared to 2019 (36.7% vs. 15.4%, respectively). Interestingly, there was no statistically significant association between COVID-19 infection status and mortality during the 2020 period. Patients with aneurysmal SAH treated during the pandemic had a higher proportion of sepsis, respiratory failure, acute kidney failure, and mortality compared to the pre-pandemic period. Reallocating healthcare resources to prioritize COVID-19 patients may have inadvertently neglected or delayed care for patients with other emergency conditions, such as aneurysmal SAH. This highlights the importance of maintaining adequate care for non-infectious emergencies during a pandemic.Keywords
This publication has 26 references indexed in Scilit:
- Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case seriesBrain, Behavior, and Immunity, 2020
- Impact of COVID-19 pandemic on subarachnoid hemorrhageJournal of Neurosurgical Sciences, 2020
- Potential Indirect Effects of the COVID-19 Pandemic on Use of Emergency Departments for Acute Life-Threatening Conditions — United States, January–May 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Impact of the COVID-19 Pandemic on Emergency Department Visits — United States, January 1, 2019–May 30, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case SeriesCase Reports in Neurology, 2020
- Subarachnoid hemorrhage guidance in the era of the COVID-19 pandemic – An opinion to mitigate exposure and conserve personal protective equipmentJournal of Stroke and Cerebrovascular Diseases, 2020
- Fair Allocation of Scarce Medical Resources in the Time of Covid-19New England Journal of Medicine, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literatureInternational Journal of Stroke, 2020
- The predictive role of health‐promoting behaviours and perceived stress in aneurysmal ruptureJournal of Clinical Nursing, 2018